HUTCHMED (China) (HCM) Cash & Equivalents (2016 - 2025)

HUTCHMED (China) (HCM) has disclosed Cash & Equivalents for 12 consecutive years, with $57.3 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 62.77% to $57.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $57.3 million through Dec 2025, down 62.77% year-over-year, with the annual reading at $57.3 million for FY2025, 62.77% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $57.3 million at HUTCHMED (China), down from $154.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $377.5 million in Q4 2021, with the low at $57.3 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $237.1 million, with a median of $283.6 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents surged 329.87% in 2021, then tumbled 62.77% in 2025.
  • Over 5 years, Cash & Equivalents stood at $377.5 million in 2021, then fell by 17.02% to $313.3 million in 2022, then fell by 9.48% to $283.6 million in 2023, then tumbled by 45.71% to $154.0 million in 2024, then crashed by 62.77% to $57.3 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $57.3 million, $154.0 million, and $283.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.